EUVIMEDOpdag EUVIMED
Querschnittstudie

Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey

Lauren Gresham, Grant Randall, Jesalyn A Tate

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.9105 ↗

At a glance

Querschnittstudie in Journal of Drugs in Dermatology, 2025. Written by Lauren Gresham and 2 co-authors. Major MEDLINE topics: Mohs Surgery, Basal Cell Carcinoma, Hedgehog Proteins, Neoadjuvant Therapy. Cited 1 times so far (Crossref).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Recent studies have demonstrated functional and cosmetic benefits with the use of hedgehog pathway inhibitors in the neoadjuvant setting for basal cell carcinoma (BCC). This study investigated the current use of neoadjuvant therapy by Mohs surgeons for the treatment of BCC with an anonymous REDcap survey distributed to members of the American College of Mohs Surgery. In the study population, a considerable percentage (22%) of Mohs surgeons reported current use of neoadjuvant hedgehog inhibitors for BCC prior to Mohs surgery. Among this group, there is wide variation in BCC size, location, target tumor size reduction, and average length of therapy for their use of neoadjuvant hedgehog inhibitors prior to Mohs surgery. Concerns about adverse effects and creating a discontinuous tumor were the most cited reasons not to treat patients with neoadjuvant hedgehog inhibitors prior to Mohs surgery. Given there is better tolerability of hedgehog pathway inhibitors when used for shorter treatment duration, hedgehog pathway inhibitors may be most useful in the neoadjuvant setting to maximize clinical benefit and minimize toxicity.

Subjects

MeSH terms (MEDLINE)

Mohs SurgeryBasal Cell CarcinomaHedgehog ProteinsNeoadjuvant TherapySkin NeoplasmsSurgeonsPractice Patterns, Physicians'Antineoplastic AgentsHumansCross-Sectional StudiesSurveys and Questionnaires

Substances

Hedgehog ProteinsAntineoplastic Agents

Cite

APA

Gresham, L., Randall, G., & Tate, J. A. (2025). Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9105

Vancouver

Gresham L, Randall G, Tate JA. Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9105

BibTeX
@article{Gresham2025,
  author = {Gresham, Lauren and Randall, Grant and Tate, Jesalyn A},
  title = {Current Use of Neoadjuvant Hedgehog Inhibitors Among Mohs Surgeons: Results of a Cross-Sectional Survey},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.9105}
}
Start for free →